(NASDAQ: APYX) Apyx Medical's forecast annual revenue growth rate of 11.47% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Apyx Medical's revenue in 2026 is $52,844,000.On average, 7 Wall Street analysts forecast APYX's revenue for 2026 to be $2,473,947,743, with the lowest APYX revenue forecast at $2,361,176,149, and the highest APYX revenue forecast at $2,559,864,973. On average, 6 Wall Street analysts forecast APYX's revenue for 2027 to be $2,723,333,588, with the lowest APYX revenue forecast at $2,532,257,684, and the highest APYX revenue forecast at $2,885,589,156.
In 2028, APYX is forecast to generate $3,098,374,428 in revenue, with the lowest revenue forecast at $2,976,902,356 and the highest revenue forecast at $3,189,520,312.